Cargando…

Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

BACKGROUND: Candida represents the most common cause of invasive fungal disease, and candidal blood stream infections (CBSI) are prevalent in the ICU. Inappropriate antifungal therapy (IAT) is known to increase a patient's risk for death. We hypothesized that in an ICU cohort it would also adve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zilberberg, Marya D, Kollef, Marin H, Arnold, Heather, Labelle, Andrew, Micek, Scott T, Kothari, Smita, Shorr, Andrew F
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890008/ https://www.ncbi.nlm.nih.gov/pubmed/20525301 http://dx.doi.org/10.1186/1471-2334-10-150

Ejemplares similares

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2009)

1658 C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients
por: Zilberberg, Marya D., et al.
Publicado: (2014)

718 Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study
por: Shorr, Andrew F., et al.
Publicado: (2014)

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study
por: Shorr, Andrew F, et al.
Publicado: (2014)

Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
por: Zilberberg, Marya D, et al.
Publicado: (2014)

Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study
por: Shorr, Andrew F., et al.
Publicado: (2015)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

Inappropriate Empiric Therapy Impacts Complications and Hospital Resource Utilization Differentially Among Different Types of Bacterial Nosocomial Pneumonia: A Cohort Study, United States, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2016)

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study
por: Shorr, Andrew F, et al.
Publicado: (2013)

Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
por: Zilberberg, Marya D., et al.
Publicado: (2008)

Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis
por: Zilberberg, Marya D., et al.
Publicado: (2017)

Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock
por: Micek, Scott, et al.
Publicado: (2017)

Timing of antibiotic therapy in the ICU
por: Kollef, Marin H., et al.
Publicado: (2021)

Candidemia on presentation to the hospital: development and validation of a risk score
por: Shorr, Andrew F, et al.
Publicado: (2009)

The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

1455. Epidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients With Complicated Urinary Tract Infections in the United States, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

Impact of empirical treatment with antifungal agents on survival of patients with candidemia
por: Poves-Alvarez, Rodrigo, et al.
Publicado: (2019)

Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning
por: Zilberberg, Marya D, et al.
Publicado: (2008)

Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2007)

Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation
por: Zilberberg, Marya D, et al.
Publicado: (2012)

Statistics on steroids: How recognizing competing risks gets us closer to the truth about COVID-19-associated VAP
por: Shorr, Andrew F., et al.
Publicado: (2022)

Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department
por: Micek, Scott T, et al.
Publicado: (2014)

2259. Predictors of Empiric Carbapenem Therapy in Complicated Intra-Abdominal Infections in the United States, 2013–2017: A Retrospective Cohort Study
por: Zilberberg, Marya, et al.
Publicado: (2019)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials
por: Burnham, Jason P., et al.
Publicado: (2017)

Gram-negative resistance and need for ICU among urinary tract infections in the United States
por: Zilberberg, M, et al.
Publicado: (2013)

1314. Descriptive Epidemiology of 30-day Readmissions among Survivors of Hospitalization with Bacterial Nosocomial Pneumonia in the US, 2012-2019
por: Zilberberg, Marya, et al.
Publicado: (2021)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

1430. Descriptive Epidemiology of Emergency Department Visits with cUTI in the US, 2012-2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Validation of an Empiric Candidemia Treatment Algorithm
por: Stack, Conor M, et al.
Publicado: (2017)

Time Trends in the Burden of Hospitalizations with Invasive Aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D, et al.
Publicado: (2017)

1427. Healthcare Resource Utilization During Hospitalizations with UTI in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013
por: Zilberberg, Marya D., et al.
Publicado: (2019)

Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States
por: Kaye, Keith S, et al.
Publicado: (2019)

Multiple antimicrobial resistance and outcomes among hospitalized patients with complicated urinary tract infections in the US, 2013–2018: a retrospective cohort study
por: Zilberberg, Marya D., et al.
Publicado: (2021)

Descriptive epidemiology and outcomes of emergency department visits with complicated urinary tract infections in the United States, 2016–2018
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018
por: Zilberberg, Marya D, et al.
Publicado: (2022)

146 Review of Empiric Echinocandin Therapy for Candidemia
por: Amado, Cristina, et al.
Publicado: (2014)

Descriptive epidemiology of hospitalized patients with bacterial nosocomial pneumonia who experience 30-day readmission in the US, 2014–2019
por: Zilberberg, Marya D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_44ou7djqsorehlu7dnki402ujn